Effect of DNA-binding Drugs on Early Growth Response Factor-1 and TATA Box-binding Protein Complex Formation with the Herpes Simplex Virus Latency Promoter
Open Access
- 1 September 1996
- journal article
- Published by Elsevier
- Vol. 271 (39), 23999-24004
- https://doi.org/10.1074/jbc.271.39.23999
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- TBP binding to the TATA box induces a specific downstream unwinding site that is targeted by pluramycinChemistry & Biology, 1995
- Comparison of the sequence selectivity of the DNA-alkylating pluramycin antitumour antibiotics DC92-B and hedamycinChemico-Biological Interactions, 1995
- The observation of a hedamycin‐d(CACGTG)2 covalent adduct by electrospray mass spectrometryFEBS Letters, 1995
- Oligonucleotide Studies of Sequence-Specific Binding of Chromomycin A3 to DNABiochemistry, 1994
- Structure of the altromycin B (N7-guanine)-DNA adduct. A proposed prototypic DNA adduct structure for the pluramycin antitumor antibioticsBiochemistry, 1993
- Minor‐groove binders are inhibitors of the catalytic activity of DNA gyrasesFEBS Letters, 1993
- Mithramycin blocks protein binding and function of the SV40 early promoter.Journal of Clinical Investigation, 1989
- Solution structure of the chromomycin-DNA complexBiochemistry, 1989
- Specific activation of transcription initiation by the sequence-specific DNA-binding agents distamycin A and netropsinBiochemistry, 1987
- Binding of hedamycin to deoxyribonucleic acid and chromatin of testis and liverBiochemistry, 1978